Cincinnati, United States
Eccrine Systems, Inc. is disrupting the healthcare industry with its innovative approach to medication monitoring. The company's slogan "Personalizing Pharmacotherapy" reflects its core mission of revolutionizing medication management through cutting-edge technology. Established in 2013, Eccrine Systems, Inc. operates at the intersection of Biotechnology, Medical Devices, and Autonomous and Sensor Tech.
The company's breakthrough platform for remote, non-invasive, and quantitative medication monitoring via sweat has the potential to significantly impact various aspects of healthcare. This technology not only enables personalized pharmacotherapy but also facilitates applications such as opioid compliance and precision dosing of narrow therapeutic index drugs in critical fields like oncology and organ transplant.
Furthermore, with its latest Series B investment received on October 17, 2019, Eccrine Systems, Inc. has demonstrated its appeal to investors seeking to support groundbreaking solutions in the healthcare space. The absence of specific information about the investors in the last investment round leaves room for speculation and curiosity regarding potential strategic partnerships or backers.
